---
category: news
title: "Roivant Dives Deeper into AI with Silicon Therapeutics Purchase"
excerpt: "Roivant Sciences, the umbrella company for Vivek Ramaswamy’s series of ‘vant companies, acquired Silicon Therapeutics for $450 million in Roivant equity."
publishedDateTime: 2021-02-26T16:05:00Z
originalUrl: "https://www.pharmalive.com/roivant-dives-deeper-into-ai-with-silicon-therapeutics-purchase/"
webUrl: "https://www.pharmalive.com/roivant-dives-deeper-into-ai-with-silicon-therapeutics-purchase/"
type: article
quality: 39
heat: 39
published: false

provider:
  name: PharmaLive
  domain: pharmalive.com

topics:
  - AI Hardware
  - AI

images:
  - url: "https://www.pharmalive.com/wp-content/uploads/2021/02/Roivant-Dives-Deeper-into-AI-with-450-Million-Buy-of-Silicon-Therapeutics-BioSpae-2-26-21.jpeg"
    width: 625
    height: 350
    isCached: true

related:
  - title: "Roivant extends AI drug discovery reach with $450M Silicon Therapeutics buyout"
    excerpt: "Roivant Sciences is expanding its drug discovery and design capabilities via a stock deal to acquire Silicon Therapeutics. The Boston startup uses physics-based modeling to simulate proteins and the small molecules that bind to them."
    publishedDateTime: 2021-02-26T20:35:00Z
    webUrl: "https://medcitynews.com/2021/02/roivant-extends-ai-drug-discovery-reach-with-450m-silicon-therapeutics-buyout/"
    type: article
    provider:
      name: MedCity News
      domain: medcitynews.com
    quality: 33
    images:
      - url: "https://medcitynews.com/uploads/2021/02/GettyImages-1093880948.jpg"
        width: 724
        height: 483
        isCached: true

secured: "ieTKmB6SwjQ66RpFnEGocj66FdQui19bcZjwT1NpNn/q72ghN1SdXTnrPbNCqM3p84kwsas8YqzCPsQgxEFnohi76h0RkHvZbLVxT0IxQEeV7IFodxeWrKRHIOv85ZrNxoj+khhWHDTxD0bETwCkVG7zTZAFaKbv8Cj3gR0Lgj2LQwUKNaxZYB0xUT+4egzLGVVANXHD2t48YuZsPa05wRVqafeazNPTse3F8dNTvLQQSIQ3XkacTEH0aPzM7nP7hll22dwHWuWaEqg1TXG95EcGGTPPFP4H0YFznqQfzOpD7rig727Dn4UcJYgvBbWc+vUshkhQmj4Kv4jEcFuLKEnLJP1MknwNo066IH9uWdE=;1yRFoiNcQdPeqmhFYi+1hQ=="
---

